Mexico or Brazil – what is worth knowing when exporting cosmetics? Before exporting cosmetics to Mexico or Brazil and proving compliance with regulations then placing them on the market, the exporter must prepare and submit the appropriate supporting documentation to the local legal representative/importer. Neither country allows direct registration by foreign manufacturers – regulatory compliance is assessed locally, and a marketing authorization (or equivalent) is issued to the...

In silico QSAR (Quantitative Structure–Activity Relationship) tools have become essential for predicting toxicity, skin sensitization, and environmental impact early in product development. Life Cycle Sustainability Assessment (LCSA) is, however, increasingly used in the cosmetics sector to support regulatory compliance, packaging design decisions, and substantiation of environmental claims. Life cycle–based methodologies are becoming central to meeting evolving European regulatory and...

Prostaglandin analogues (PGAs) are synthetic, first-line, once-daily eye drops that reduce elevated intraocular pressure (IOP) in glaucoma and ocular hypertension by increasing uveoscleral outflow. These compounds mimic naturally occurring prostaglandins, specifically targeting receptors to relax eye muscles and enhance aqueous humor drainage. There is no formal ban on the use of prostaglandin analogues in cosmetic products in the EU as of March 2026. However, the situation is very close to...